Why a Clinical Genetic Test Report May Not Include Everything in Your Sequencing Results

It is a common and understandable moment of confusion. You look at a clinical genetic test report from a healthcare provider, then you look at your Sequencing results, and the two do not line up. One mentions a gene or a condition that the other never brings up at all.

In almost every case, this does not mean one of them is wrong. It usually means the two were built to answer different questions.

Here is how to make sense of the difference.

Three different things: tested, analyzed, and reported

The single most useful idea is that a genetic test has three layers, and they are not the same size.

What was tested refers to the DNA regions or specific positions the laboratory actually examined. This might be selected positions, one gene, a panel of 20 or 200 genes, the protein-coding portion of your genome (an exome), or close to your whole genome.

What was analyzed is the part of that data the lab actually looked at closely. Even when a lab sequences a large region, it often narrows its review to the genes connected to your specific clinical question.

What was reported is the small subset of findings that met the lab's criteria for inclusion in the written report.

Each layer is often smaller than the one before it. A gene can be tested, never analyzed, and never appear in your report, even though the data exists.

This is not an oversight. It is how clinical reporting is designed to work.

Clinical tests usually begin with a specific question

Clinical genetic testing is typically ordered to answer something concrete. A clinician is trying to explain a set of symptoms, confirm a suspected diagnosis, assess a risk suggested by family history, or guide a treatment decision.

That reason for testing shapes everything downstream. The gene list, the analysis, and the report are all usually built around it, drawing on your symptoms, medical history, family history, and sometimes ancestry or age at onset.

So a report ordered to investigate unexplained high cholesterol is generally not designed to tell you anything about hearing loss, cancer risk, or ancestry. Those topics were simply never part of the question.

Different tests may examine different parts of your DNA

Different technologies capture different things. Genotyping arrays check a predefined set of positions. Exome sequencing focuses on the parts of genes that contain instructions for making proteins, which make up a small fraction of the genome. Whole genome sequencing reads much more, including regions between genes.

Some genetic changes are also harder for certain methods to detect reliably. Repeat expansions, large structural changes, copy-number changes, and some changes in mitochondrial DNA may require specific techniques or follow-up testing.

Coverage can vary too. Even within a single test, some regions are read more thoroughly than others, and labs often note regions with limited coverage in the fine print.

The practical takeaway is that two tests can genuinely hold different information about you, even before they interpret the results.

Reporting criteria are deliberately narrow

Every person carries millions of genetic differences compared with a standard reference genome, so clinical labs apply filters. For variants related to inherited conditions, many labs use the classification framework published in 2015 by the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP), which sorts variants into five categories: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign.

Many diagnostic reports focus on pathogenic and likely pathogenic variants in genes relevant to the reason for testing. Reporting around variants of uncertain significance varies between laboratories. Some include them, some do not, and some include only a subset.

There is also a separate type of result called secondary findings. The ACMG maintains a list of genes linked to conditions where early action may meaningfully help, and labs may review those genes during exome or genome sequencing performed for another reason. Reporting is generally limited to pathogenic and likely pathogenic variants, is usually offered as a choice you can accept or decline, and is not available with every test.

So a gene can be included in your test data, reviewed by the lab, and still have no finding reported because no variant met the reporting threshold.

Not every finding means the same thing

This is where comparing two reports side by side gets tricky, because findings that look similar on screen can carry very different weight.

Disease-causing findings are variants classified as pathogenic or likely pathogenic in a gene with a well-established link to a condition. These carry the most clinical weight, though they still need to be interpreted alongside your symptoms, family history, and how the condition is inherited.

Uncertain findings are variants of uncertain significance. The honest meaning is that there is not yet enough evidence to call them harmful or harmless. A variant of uncertain significance is not a diagnosis and is generally not used on its own to guide medical decisions.

Risk associations generally come from population research. They describe how often a condition occurs in groups of people who share a genetic pattern. Common examples include single markers linked to shifts in risk and polygenic scores that combine many markers. These describe tendencies across populations rather than a verdict about one person, and their accuracy can vary depending on which populations the underlying research included.

A report that lists many risk associations is not more thorough than one that lists a single pathogenic variant. They are measuring different things.

Interpretation has a date attached to it

A genetic report is a snapshot of what was known on the day it was issued.

Evidence accumulates. Variants may be reclassified as more families are studied and as large population databases grow. Movement can go in both directions: some variants of uncertain significance are later reclassified as benign, and others are reclassified as likely pathogenic.

Two reports written years apart can therefore describe the same variant differently, and the newer interpretation is not automatically the more conservative one.

Reports can also use different versions of the reference genome, which means the same variant may be listed at different coordinates. That can make an identical finding look like two different ones.

A simple example

Imagine someone named Alex.

Alex has persistently high cholesterol and a father who had a heart attack at 45. A clinician orders a clinical panel for familial hypercholesterolemia covering a small set of genes known to cause it. The result comes back negative, meaning no pathogenic or likely pathogenic variant was found in those genes.

Later, Alex looks at Sequencing results and sees entries that mention a carrier status finding for an unrelated recessive condition, a variant of uncertain significance in a connective tissue gene, and several risk associations for common conditions.

None of this contradicts the clinical report.

The clinical panel never examined the carrier gene or the connective tissue gene, because neither was part of the clinical question. The risk associations are population-level statistics, not diagnostic findings, so they would not have been included in this panel report.

And importantly, the negative panel result does not mean familial hypercholesterolemia is ruled out. It means no qualifying variant was found in the genes that were examined, using the methods that were used, under the reporting criteria that were applied. Many people with a clinical picture of familial hypercholesterolemia have no identifiable variant on genetic testing.

Alex now has two accurate documents that answer two different questions.

More findings does not mean more certainty

A longer report is not necessarily more conclusive. Additional findings do not establish a diagnosis on their own, and the presence of extra entries does not make one source more accurate than another.

A diagnosis is a clinical judgment. It brings together symptoms, examination, family history, laboratory results, imaging where relevant, and genetic findings when they apply. Genetic information can be central to some diagnoses and one part of the picture for others.

Similarly, a condition that does not appear in a report has not necessarily been ruled out. It may never have been looked for.

A checklist for comparing two reports

If you are holding a clinical report and your Sequencing results and want to compare them sensibly, work through these questions for each one.

1. What was the reason for testing? Look for the clinical indication near the top of the report.
2. Which genes were included? Many reports list the exact genes examined, often in an appendix or methods section.
3. What method was used? Single gene, panel, exome, genome, or array. This tells you what kinds of changes could realistically be detected.
4. Were there coverage limitations? Check the methods and limitations section for regions that were not fully read.
5. What was the reporting policy? Note whether variants of uncertain significance were included and whether secondary findings were offered or declined.
6. How is each finding classified? Separate pathogenic and likely pathogenic findings from uncertain findings and from risk associations.
7. When was it issued? Note the report date and the reference genome build, if listed.
8. Is the same variant described twice? Compare gene name plus the specific variant notation, not just the condition name.

After working through both, the overlap and the gaps usually become much easier to explain.

Talking it through with a professional

If something in your results feels significant, bring it to a healthcare professional or a genetic counselor rather than acting on it alone. Genetic counselors are specifically trained for this kind of conversation.

A few questions that tend to make the appointment more productive:

• Was this gene included in the clinical test I already had?
• If it was included, was it analyzed, and would a finding like this have been reported?
• Is this finding considered disease-causing, uncertain, or a risk association?
• Does this fit with my symptoms and family history, or is it incidental?
• Would confirmatory testing in a clinical laboratory be appropriate here?
• Is it worth asking for reanalysis of my earlier test given newer evidence?

It also helps to bring the actual documents. The methods and limitations sections, which are easy to skip, are often where the answer lives.

One note about Sequencing results specifically

Results, apps, and AI-generated reports from Sequencing are intended to be informational and educational. They are not a clinical diagnosis and are not a substitute for advice from a qualified healthcare professional.

If a finding in your Sequencing results looks medically important, the appropriate next step is to discuss it with a clinician or genetic counselor, who can advise whether confirmatory testing in a clinical laboratory makes sense for your situation.

What exactly is covered, how it is analyzed, and how it is presented depend on the specific test and report you have, so treat the details on your own report as the authority.

The bottom line

A clinical report and a broad genomic result are not competing accounts of your DNA. They may offer different views, using different tools, for different reasons, or at different times.

A shorter clinical report usually reflects a focused question that was investigated carefully, not a less thorough look at you. And a finding that appears in one place and not the other is an invitation to ask a good question, not a reason to assume something went wrong.